Patent holdings for IPC class A61K 31/00

Total number of patents in this class: 7820

10-year publication summary

502
501
461
429
457
429
458
474
514
339
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Inserm (institut National de La Sante et de La Recherche Medicale)
3369
100
Novartis AG
10686
74
The Regents of the University of California
20172
70
Centre National de La Recherche Scientifique
10611
49
Institut National de La Sante et de La Recherche Medicale (inserm)
2934
48
The Johns Hopkins University
5734
47
The Board of Trustees of the Leland Stanford Junior University
6500
40
Boehringer Ingelheim International GmbH
4641
33
Genentech, Inc.
4005
29
Duke University
3095
27
Buzzelet Development and Technologies Ltd
97
27
F. Hoffmann-La Roche AG
7942
26
AstraZeneca AB
2854
26
Gilead Sciences, Inc.
2063
26
Massachusetts Institute of Technology
10127
25
Cellixbio Private Limited
155
25
Vanda Pharmaceuticals, Inc.
367
25
Centre National de La Recherche Scientifique (cnrs)
3094
25
LTS Lohmann Therapie-Systeme AG
712
24
Chiesi Farmaceutici S.p.A.
974
23
Other owners 7051